Form 8-K - Current report:
SEC Accession No. 0001641172-25-011486
Filing Date
2025-05-19
Accepted
2025-05-19 16:37:06
Documents
14
Period of Report
2025-05-19
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 45395
  Complete submission text file 0001641172-25-011486.txt   258335

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE biaf-20250519.xsd EX-101.SCH 3785
3 XBRL DEFINITION FILE biaf-20250519_def.xml EX-101.DEF 26626
4 XBRL LABEL FILE biaf-20250519_lab.xml EX-101.LAB 36673
5 XBRL PRESENTATION FILE biaf-20250519_pre.xml EX-101.PRE 25250
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5815
Mailing Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217
Business Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41463 | Film No.: 25964553
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)